Large EST library for kiwifruit published, fleshing out apples and pears

A research director at Los Alamos National Laboratories said the addition of a peta-scale supercomputer is as big a leap forward as when scientists got their hands on their first computer ever.

The pharmaceutical industry should fight a major battle to prolong patent protection and encourage real innovation and discovery, a leading pharmacologist told a Melbourne audience last week.

Ruth Beran talks with Iatia boss Charles Laycock about the importance of being smart and flexible in designing a good biotech business model.

Solbec Pharmaceuticals' (ASX:SBP) devil's apple-derived drug Coramsine (SBP002) has met the primary endpoint of safety and tolerability for the two-hour infusion cohort of its single agent phase I clinical trial for advanced solid tumours.

Perth-based Solbec Pharmaceuticals (ASX:SBP) has paid a AUD$33,000 fine after being issued with an infringement notice by the Australian Securities and Investments Commission (ASIC) for allegedly failing to disclose information to the Australian Stock Exchange (ASX) relating to a drug trial.